The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia.  Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.

We are committed to

  • Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
  • Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
  • Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure

Meet the Myeloma Center June Edition
Sharmilan Thanendrarajan, M.D.

Cure in Multiple Myeloma – What is the Formula? Sharmilan Thanendrarajan, M.D. Watch Now

  • Myeloma Patient in Remission, Grateful for Additional TimeJune 5, 2019

    Linda Reins of Tulsa, Oklahoma, and her husband Robert recently learned she is in complete remission. “Dr van Rhee has given me time and hope,” she said. Read more Myeloma Patient in Remission, Grateful for Additional Time Linda Haymes June 4, 2019 | Linda Reins, 73, of Tulsa, Oklahoma, is no stranger to cancer. In…

  • Welcome Hayley BiermanMay 30, 2019


    Dear Patients, It is my pleasure to inform you that Hayley Bierman has accepted the position as an Advanced Nurse Practitioner in my clinic. Hayley has worked in the Winthrop P. Rockefeller Cancer Institute’s Infusion 4 clinic since 2012 providing care to our patients undergoing chemotherapy and stem cell transplantation.  Patients and caregivers can reach…

  • Commentary by UAMS’ van Rhee Featured in Blood JournalMay 23, 2019

    Commentary by UAMS’ van Rhee Featured in Blood Journal

    “Significant progress has been made in recent years in the field of multicentric Castleman disease,” Frits van Rhee wrote in a recent commentary in Blood, a publication by the American Society of Hematology, noting several advancements. Read more Commentary by UAMS’ van Rhee Featured in Blood Journal Linda Haymes May. 22, 2019 | Frits van…

View Myeloma News Archive